wegovy news - Search News

News

Wegovy maker warns of slower profits

Wegovy maker Novo's profit warning triggers $70 billion share rout

Pedersen, Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) -Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO,

BBC on MSN · 1d

Wegovy maker warns of slower profits as rivals bite

While Novo Nordisk blamed rival drugs and its own tepid expansion for downgrades to sales and profit growth, some analysts said the company had been too slow to pursue the market for people willing to pay for its weight-loss treatments.

CNBC on MSN · 1d

Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market. Shares were down 17% at 12:30 p.m. London time, shortly after the announcement (7:30 a.m. ET).

1don MSN

Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

2don MSN

The Patients Forced to Switch From Zepbound to Wegovy

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Fierce Pharma6d

Viatris beats Novo in semaglutide patent feud, clearing hurdle for potential Wegovy generic

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Is your Wegovy real? Here’s how to ID fake weight loss drugs

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

1mon

Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

2don MSN

Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban

A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will need to show more robust growth in the months ahead to bolster market ...

Forbes Daily: Ozempic And Wegovy Maker Loses Big On Wall Street

Today’s Forbes Daily covers Pacific tsunami activity after powerful quake, Trump breaks with Netanyahu over Gaza, the Forbes 50 Over 50, a railroad merger and more.

Devdiscourse1d

A New Era at Novo Nordisk: Leadership Change and Market Challenges

Novo Nordisk announces a leadership transition as Lars Fruergaard Jørgensen welcomes new CEO Doug Doustdar. Doustdar aims to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results